Quest Diagnostics can benefit from continued demand for specific diagnostic testing across a broad range of clinical areas.

DGX teams up with Epic on Project Nova to streamline lab testing, boost efficiency, and enhance patient and provider experiences.

During a talk at the Jefferies Healthcare Services Conference this week, CFO Sam Samad said the business has exceeded the company's expectations.

Whoop introduces Advanced Labs, letting users schedule blood tests via the app through Quest Diagnostics, linking biomarker ...

Quest Diagnostics' Haystack Oncology joins Rutgers Cancer Institute to study how its ctDNA MRD test can guide therapy for stage II/III lung cancer.

Quest Diagnostics Incorporated ( NYSE: DGX) Jefferies 2025 Healthcare Services Conference September 29, 2025 4:35 PM EDT Okay, we're going to kick it off. I'm Tycho Peterson from the life science team ...

Quest Diagnostics stock reached a significant milestone, achieving an all-time high of $190.93. This new peak underscores the company’s robust performance, with the stock delivering an impressive ...

According to WSJ, Dr. Tom Delbanco, a primary-care expert at Harvard Medical School, said that “the more a patient gets ...

What risks might be hiding under the surface? What changes could I make now to support myself in the decades ahead? That curiosity led me to Everlywell—a health platform that brings clinical-level lab ...

Barclays raised the firm’s price target on Quest Diagnostics (DGX) to $190 from $185 and keeps an Equal Weight rating on the shares as part of a ...

People increasingly turn to do-it-yourself healthcare amid long waits for medical appointments and a rise in self-care ...

Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detection-Offered as a laboratory-developed test at ...